October 11, 2013
A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.'s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.
November 05, 2012
A New York federal jury hit Novartis Pharmaceuticals Corp. with a $10.5 million verdict Friday in a suit brought by a woman whose jaw deteriorated after she took the bone drug Zometa, snapping a string of victories for the company in multidistrict litigation over the drug.